Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Biobanking Market Overview
3.1 Global Biobanking Market
3.1.1 Global Biobanking Market Historical Value (2019-2025)
3.1.2 Global Biobanking Market Forecast Value (2026-2035)
3.2 Latin America Biobanking Market
3.2.1 Latin America Biobanking Market Historical Value (2019-2025)
3.2.2 Latin America Biobanking Market Forecast Value (2026-2035)
4 Latin America Biobanking Market Landscape*
4.1 Latin America Biobanking Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Biobanking Market: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Sample Type
4.2.3 Analysis by Storage Type
5 Latin America Biobanking Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Latin America Biobanking Market Segmentation (2019-2035)
6.1 Latin America Biobanking Market (2019-2035) by Product Type
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Consumables
6.1.4 Software & Services
6.2 Latin America Biobanking Market (2019-2035) by Sample Type
6.2.1 Market Overview
6.2.2 Blood
6.2.3 Human Tissues
6.2.4 Cell Lines
6.2.5 Nucleic Acids
6.2.6 Others
6.3 Latin America Biobanking Market (2019-2035) by Storage Type
6.3.1 Market Overview
6.3.2 Manual Storage
6.3.3 Automated Storage
6.4 Latin America Biobanking Market (2019-2035) by Purpose
6.4.1 Market Overview
6.4.2 Clinical
6.4.3 Research
6.5 Latin America Biobanking Market (2019-2035) by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical & Biotechnology Companies & CROs
6.5.3 Hospitals
6.5.4 Others
6.6 Latin America Biobanking Market (2019-2035) by Country
6.6.1 Market Overview
6.6.2 Brazil
6.6.3 Argentina
6.6.4 Mexico
6.6.5 Others
7 Brazil Biobanking Market (2019-2035)
7.1 Brazil Biobanking Market (2019-2035) by Product Type
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Consumables
7.1.4 Software & Services
7.2 Brazil Biobanking Market (2019-2035) by Sample Type
7.2.1 Market Overview
7.2.2 Blood
7.2.3 Human Tissues
7.2.4 Cell Lines
7.2.5 Nucleic Acids
7.2.6 Others
7.3 Brazil Biobanking Market (2019-2035) by Storage Type
7.3.1 Market Overview
7.3.2 Manual Storage
7.3.3 Automated Storage
7.4 Brazil Biobanking Market (2019-2035) by Purpose
7.4.1 Market Overview
7.4.2 Clinical
7.4.3 Research
7.5 Brazil Biobanking Market (2019-2035) by End User
7.5.1 Market Overview
7.5.2 Pharmaceutical & Biotechnology Companies & CROs
7.5.3 Hospitals
7.5.4 Others
8 Argentina Biobanking Market (2019-2035)
8.1 Argentina Biobanking Market (2019-2035) by Product Type
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Consumables
8.1.4 Software & Services
8.2 Argentina Biobanking Market (2019-2035) by Sample Type
8.2.1 Market Overview
8.2.2 Blood
8.2.3 Human Tissues
8.2.4 Cell Lines
8.2.5 Nucleic Acids
8.2.6 Others
8.3 Argentina Biobanking Market (2019-2035) by Storage Type
8.3.1 Market Overview
8.3.2 Manual Storage
8.3.3 Automated Storage
8.4 Argentina Biobanking Market (2019-2035) by Purpose
8.4.1 Market Overview
8.4.2 Clinical
8.4.3 Research
8.5 Argentina Biobanking Market (2019-2035) by End User
8.5.1 Market Overview
8.5.2 Pharmaceutical & Biotechnology Companies & CROs
8.5.3 Hospitals
8.5.4 Others
9 Mexico Biobanking Market (2019-2035)
9.1 Mexico Biobanking Market (2019-2035) by Product Type
9.1.1 Market Overview
9.1.2 Equipment
9.1.3 Consumables
9.1.4 Software & Services
9.2 Mexico Biobanking Market (2019-2035) by Sample Type
9.2.1 Market Overview
9.2.2 Blood
9.2.3 Human Tissues
9.2.4 Cell Lines
9.2.5 Nucleic Acids
9.2.6 Others
9.3 Mexico Biobanking Market (2019-2035) by Storage Type
9.3.1 Market Overview
9.3.2 Manual Storage
9.3.3 Automated Storage
9.4 Mexico Biobanking Market (2019-2035) by Purpose
9.4.1 Market Overview
9.4.2 Clinical
9.4.3 Research
9.5 Mexico Biobanking Market (2019-2035) by End User
9.5.1 Market Overview
9.5.2 Pharmaceutical & Biotechnology Companies & CROs
9.5.3 Hospitals
9.5.4 Others
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Strategic Initiatives
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Initiatives
12.3 Analysis by Joint Ventures
12.4 Analysis by Leading Players
12.5 Analysis by Geography
13 Supplier Landscape
13.1 Market Share Analysis
13.2 Thermo Fisher Scientific Inc.
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Company News and Development
13.2.5 Certifications
13.3 Brooks Automation, Inc.
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Company News and Development
13.3.5 Certifications
13.4 Qiagen N.V.
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Company News and Development
13.4.5 Certifications
13.5 Tecan Group Ltd.
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Company News and Development
13.5.5 Certifications
13.6 Hamilton Company
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Company News and Development
13.6.5 Certifications
13.7 PHC Holdings Corporation
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Company News and Development
13.7.5 Certifications
13.8 Panasonic Healthcare Holdings Co., Ltd.
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Company News and Development
13.8.5 Certifications
13.9 Greiner Bio-One International GmbH
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Company News and Development
13.9.5 Certifications
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*